BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14606338)

  • 1. Infections due to non-neoformans cryptococcal species.
    McCurdy LH; Morrow JD
    Compr Ther; 2003; 29(2-3):95-101. PubMed ID: 14606338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
    Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
    Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
    Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
    Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
    [No Abstract]   [Full Text] [Related]  

  • 4. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tenosynovitis caused by Cryptococcus neoformans in a patient with AIDS].
    Fernández CM; Enrique Morano L; Angel Montero L
    Enferm Infecc Microbiol Clin; 2001; 19(6):285-6. PubMed ID: 11440675
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
    Lu R; Hollingsworth C; Qiu J; Wang A; Hughes E; Xin X; Konrath KM; Elsegeiny W; Park YD; Atakulu L; Craft JC; Tramont EC; Mannino R; Williamson PR
    mBio; 2019 May; 10(3):. PubMed ID: 31138748
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic humicolus cryptococcosis.
    Shinde SM; Vanarse KS; Pandit AN
    Indian Pediatr; 2004 Nov; 41(11):1162-4. PubMed ID: 15591670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
    AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular cryptococcoma.
    Wykoff CC; Albini TA; Couvillion SS; Dubovy SR; Davis JL
    Arch Ophthalmol; 2009 May; 127(5):700-2. PubMed ID: 19433726
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
    Larsen RA; Leal MA; Chan LS
    Ann Intern Med; 1990 Aug; 113(3):183-7. PubMed ID: 2197908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus neoformans infection.
    Paterson DL; Singh N
    Liver Transpl; 2002 Sep; 8(9):846-7. PubMed ID: 12200789
    [No Abstract]   [Full Text] [Related]  

  • 13. Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
    Kassi FK; Drakulovski P; Bellet V; Roger F; Chabrol A; Krasteva D; Doumbia A; Landman R; Kakou A; Reynes J; Delaporte E; Menan HEI; Bertout S
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007812. PubMed ID: 31738768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antifungal combination against Cryptococcus spp.
    Reichert-Lima F; Busso-Lopes AF; Lyra L; Peron IH; Taguchi H; Mikami Y; Kamei K; Moretti ML; Schreiber AZ
    Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen.
    Singh N; Gayowski T; Marino IR
    Transpl Int; 1998; 11(1):63-5. PubMed ID: 9503557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.
    Kordossis T; Avlami A; Velegraki A; Stefanou I; Georgakopoulos G; Papalambrou C; Legakis NJ
    Med Mycol; 1998 Oct; 36(5):335-9. PubMed ID: 10075504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
    Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
    Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
    Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA
    J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of cryptococcosis in and around Chandigarh, India, during the period 1982-91.
    Chander J; Sapra RK; Talwar P
    Mycoses; 1994; 37(1-2):23-6. PubMed ID: 7935587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.
    Allendoerfer R; Marquis AJ; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1991 Apr; 35(4):726-9. PubMed ID: 2069378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.